164 related articles for article (PubMed ID: 21528818)
21. Infusion rate and pharmacokinetics of intravenous pamidronate in the treatment of tumour-induced hypercalcaemia.
Dodwell DJ; Howell A; Morton AR; Daley-Yates PT; Hoggarth CR
Postgrad Med J; 1992 Jun; 68(800):434-9. PubMed ID: 1437922
[TBL] [Abstract][Full Text] [Related]
22. Single high-dose (45 mg) infusions of aminohydroxypropylidene diphosphonate for severe malignant hypercalcemia.
Mannix KA; Carmichael J; Harris AL; Cantwell BM
Cancer; 1989 Sep; 64(6):1358-61. PubMed ID: 2766228
[TBL] [Abstract][Full Text] [Related]
23. Oral prednisolone for management of persistent hypercalcemia afterhypercalcemic crisis in the Williams-Beuren syndrome.
Varma TH; Sahitya DSK; Dusad S; Agarwal A; Dayal D
Pediatr Endocrinol Diabetes Metab; 2018; 24(2):106-109. PubMed ID: 30300432
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of miacalcic in treating a hypercalcemia crisis caused by Williams-Beuren syndrome.
Gu Y; Gong C; Shen Y; Wu D; Liang X; Chang B; Liu Y; Wang Y
Chin Med J (Engl); 2014; 127(13):2548-9. PubMed ID: 24985599
[No Abstract] [Full Text] [Related]
25. Childhood cancer and hypercalcemia: report of a case treated with pamidronate.
Kutluk MT; Hazar V; Akyüz C; Varan A; Büyükpamukçu M
J Pediatr; 1997 May; 130(5):828-31. PubMed ID: 9152297
[TBL] [Abstract][Full Text] [Related]
26. The use of pamidronate for hypercalcemia secondary to acute vitamin D intoxication.
Lee DC; Lee GY
J Toxicol Clin Toxicol; 1998; 36(7):719-21. PubMed ID: 9865241
[TBL] [Abstract][Full Text] [Related]
27. Williams syndrome with severe hypercalcaemia.
Gupta V; Pandita A; Panghal A; Kallem VR
BMJ Case Rep; 2018 Sep; 2018():. PubMed ID: 30262523
[TBL] [Abstract][Full Text] [Related]
28. A randomised double-blind comparison of intravenous pamidronate and clodronate in the hypercalcaemia of malignancy.
Purohit OP; Radstone CR; Anthony C; Kanis JA; Coleman RE
Br J Cancer; 1995 Nov; 72(5):1289-93. PubMed ID: 7577484
[TBL] [Abstract][Full Text] [Related]
29. Use of disodium pamidronate in children with hypercalcemia awaiting liver transplantation.
Attard TM; Dhawan A; Kaufman SS; Collier DS; Langnas AN
Pediatr Transplant; 1998 May; 2(2):157-9. PubMed ID: 10082449
[TBL] [Abstract][Full Text] [Related]
30. Vitamin D intoxication and hypercalcaemia in an infant treated with pamidronate infusions.
Ezgu FS; Buyan N; Gündüz M; Tümer L; Okur I; Hasanoglu A
Eur J Pediatr; 2004 Mar; 163(3):163-5. PubMed ID: 14714183
[TBL] [Abstract][Full Text] [Related]
31. Comparative study of pamidronate disodium and etidronate disodium in the treatment of cancer-related hypercalcemia.
Gucalp R; Ritch P; Wiernik PH; Sarma PR; Keller A; Richman SP; Tauer K; Neidhart J; Mallette LE; Siegel R
J Clin Oncol; 1992 Jan; 10(1):134-42. PubMed ID: 1727915
[TBL] [Abstract][Full Text] [Related]
32. Use of Pamidronate to Treat Hypercalcemia in an Oncology Dialysis Patient: A Case Report.
Mahmoud S; Mitwally H; El Zeer HS; El Madhoun I; Khatib M
Am J Case Rep; 2018 Sep; 19():1087-1089. PubMed ID: 30209247
[TBL] [Abstract][Full Text] [Related]
33. Ibandronate, an experimental intravenous bisphosphonate for osteoporosis, bone metastases, and hypercalcemia of malignancy.
Guay DR
Pharmacotherapy; 2006 May; 26(5):655-73. PubMed ID: 16637795
[TBL] [Abstract][Full Text] [Related]
34. Pamidronate treatment for hypercalcemia in an infant receiving parenteral nutrition.
Bryowsky JJ; Bugnitz MC; Hak EB
Pharmacotherapy; 2004 Jul; 24(7):939-44. PubMed ID: 15303458
[TBL] [Abstract][Full Text] [Related]
35. The use of pamidronate in a leukemic child with immobilization hypercalcemia.
Tavil B; Sipahi T; Kara A
Leuk Res; 2006 Jul; 30(7):907-8. PubMed ID: 16289681
[No Abstract] [Full Text] [Related]
36. Efficacy and safety of pamidronate in children with vitamin D intoxication.
Kara C; Çetinkaya S; Gündüz S; Can Yılmaz G; Aycan Z; Aydın M
Pediatr Int; 2016 Jul; 58(7):562-8. PubMed ID: 26646324
[TBL] [Abstract][Full Text] [Related]
37. Effectiveness of pamidronate in severe neonatal hypercalcemia caused by subcutaneous fat necrosis: a case report.
Lombardi G; Cabano R; Bollani L; Del Forno C; Stronati M
Eur J Pediatr; 2009 May; 168(5):625-7. PubMed ID: 18726115
[TBL] [Abstract][Full Text] [Related]
38. Uses and effectiveness of pamidronate disodium for treatment of dogs and cats with hypercalcemia.
Hostutler RA; Chew DJ; Jaeger JQ; Klein S; Henderson D; DiBartola SP
J Vet Intern Med; 2005; 19(1):29-33. PubMed ID: 15715044
[TBL] [Abstract][Full Text] [Related]
39. Clodronate as a single-dose intravenous infusion effectively provides short-term correction of malignant hypercalcemia.
Atula ST; Tähtelä RK; Nevalainen JI; Pylkkänen LH
Acta Oncol; 2003; 42(7):735-40. PubMed ID: 14690159
[TBL] [Abstract][Full Text] [Related]
40. Reversal of hypercalcemic acute kidney injury by treatment with intravenous bisphosphonates.
Auron A; Tal L; Srivastava T; Alon US
Pediatr Nephrol; 2009 Mar; 24(3):613-7. PubMed ID: 18839218
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
